The actin modulator hMENA regulates GAS 6‐ AXL axis and pro‐tumor cancer/stromal cell cooperation-Reference-Cited by-同舟云学术

The actin modulator hMENA regulates GAS 6‐ AXL axis and pro‐tumor cancer/stromal cell cooperation

Published:2020-09-10 Issue:11 Volume:21 Page:
ISSN:1469-221X
Container-title:EMBO reports
language:en
Short-container-title:EMBO Rep

Author:

Melchionna Roberta¹,Spada Sheila¹,Di Modugno Francesca¹,D'Andrea Daniel²,Di Carlo Anna¹,Panetta Mariangela¹,Mileo Anna Maria¹,Sperduti Isabella³,Antoniani Barbara⁴,Gallo Enzo⁴,Lawlor Rita T⁵,Piemonti Lorenzo⁶,Visca Paolo⁴,Milella Michele⁷,Grazi Gian Luca⁸,Facciolo Francesco⁹,Chen Emily¹⁰,Scarpa Aldo⁵,Nisticò Paola¹^ORCID

Affiliation:

1. Tumor Immunology and Immunotherapy Unit IRCCS Regina Elena National Cancer Institute Rome Italy

2. Department of Medicine Centre for Cell Signaling and Inflammation Imperial College London London UK

3. Biostatistics and Scientific Direction IRCCS Regina Elena National Cancer Institute Rome Italy

4. Pathology Unit IRCCS Regina Elena National Cancer Institute Rome Italy

5. ARC‐NET Research Centre Department of Diagnostics and Public Health Section of Pathology University of Verona Verona Italy

6. Diabetes Research Institute IRCCS San Raffaele Scientific Institute Milan Italy

7. Department of Medical Oncology 1 IRCCS Regina Elena National Cancer Institute Rome Italy

8. Hepato‐pancreato‐biliary Surgery Unit IRCCS Regina Elena National Cancer Institute Rome Italy

9. Thoracic‐Surgery Unit IRCCS Regina Elena National Cancer Institute Rome Italy

10. Thermo Fisher Precision Medicine Science Center Cambridge MA USA

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

EMBO

Subject

Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/embr.202050078

Reference58 articles.

1. TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy

2. Molecular characterization of the tumor microenvironment in breast cancer

3. Ena/VASP: towards resolving a pointed controversy at the barbed end

4. Understanding the tumor immune microenvironment (TIME) for effective therapy

5. Putting tumours in context

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hallmarks of pancreatic cancer: spotlight on TAM receptors;eBioMedicine;2024-09

2. CAFs-Associated Genes (CAFGs) in Pancreatic Ductal Adenocarcinoma (PDAC) and Novel Therapeutic Strategy;International Journal of Molecular Sciences;2024-05-30

3. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer;eBioMedicine;2024-03

4. Transcription factors in fibroblast plasticity and CAF heterogeneity;Journal of Experimental & Clinical Cancer Research;2023-12-20

5. TAM family kinases as therapeutic targets at the interface of cancer and immunity;Nature Reviews Clinical Oncology;2023-09-04